Abstract
We present a case of a 75-year-old lady with effort intolerance and baseline ECG showing 2:1 atrioventricular block, in whom it was unclear as to the requirement of permanent pacing, even after long term ECG monitoring. She underwent a treadmill test during which her QRS became wide and developed complete heart block within 2 minutes of the test. Thus, a simple exercise test confirmed the level of the block to be infra nodal without the need for the invasive study. In patients with exertional symptoms, even in elderly, and in those where ECG masquerades as a benign entity, exercise testing is useful to differentiate benign cases of atrioventricular block from the more serious cases that mandate pacemaker implantation.
Keywords: Atrioventricular block, Complete heart block, Exercise test, Intra-Hisian block, Infra nodal, Coronary angiogram.
New Emirates Medical Journal
Title:A Case of 2:1 Atrio-Ventricular Block- Unraveled by Exercise Testing
Volume: 1
Author(s): Sharada S. Kalavakolanu*, Madan M. Balakrishnan and Deepesh Venkataraman
Affiliation:
- Department of Cardiology, MGM Healthcare, Aminjikarai, Chennai, Tamilnadu,India
Keywords: Atrioventricular block, Complete heart block, Exercise test, Intra-Hisian block, Infra nodal, Coronary angiogram.
Abstract: We present a case of a 75-year-old lady with effort intolerance and baseline ECG showing 2:1 atrioventricular block, in whom it was unclear as to the requirement of permanent pacing, even after long term ECG monitoring. She underwent a treadmill test during which her QRS became wide and developed complete heart block within 2 minutes of the test. Thus, a simple exercise test confirmed the level of the block to be infra nodal without the need for the invasive study. In patients with exertional symptoms, even in elderly, and in those where ECG masquerades as a benign entity, exercise testing is useful to differentiate benign cases of atrioventricular block from the more serious cases that mandate pacemaker implantation.
Export Options
About this article
Cite this article as:
Kalavakolanu S. Sharada*, Balakrishnan M. Madan and Venkataraman Deepesh , A Case of 2:1 Atrio-Ventricular Block- Unraveled by Exercise Testing, New Emirates Medical Journal 2020; 1 (2) . https://dx.doi.org/10.2174/0250688202002022001
DOI https://dx.doi.org/10.2174/0250688202002022001 |
Print ISSN 0250-6882 |
Publisher Name Bentham Science Publisher |
Online ISSN 0250-6882 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Resveratrol as an Enhancer of Apoptosis in Cancer: A Mechanistic Review
Anti-Cancer Agents in Medicinal Chemistry Macrophage Polarization as a Therapeutic Target in Myocardial Infarction
Current Drug Targets Novel Therapeutic Strategies for the Homozygous Familial Hypercholesterolemia
Recent Patents on Cardiovascular Drug Discovery Cell Therapy for the Treatment of Chronic Ischemic Heart Disease
Current Pharmaceutical Design Myocardial Infarction Following Atherosclerosis in Murine Models
Current Drug Targets Nutraceuticals, Nutritional Therapy, Phytonutrients, and Phytotherapy for Improvement of Human Health: A Perspective on Plant Biotechnology Application
Recent Patents on Biotechnology Peculiarities of the Clinical Course of Oxidative Protein and Lipid Modification in Children with Acute Rheumatic Fever
Endocrine, Metabolic & Immune Disorders - Drug Targets Mechanisms Underlying the Cardiovascular Effects of COX-Inhibition: Benefits and Risks
Current Pharmaceutical Design Effect on Serum Uric Acid Levels of Drugs Prescribed for Indications other than Treating Hyperuricaemia
Current Pharmaceutical Design Lipid Messengers as Targets for Antiangiogenic Therapy
Current Pharmaceutical Design Therapeutic Options and Emerging Alternatives for Multidrug Resistant Staphylococcal Infections
Current Pharmaceutical Design Neurotrophic and Neuroprotective Effects of Muscle Contraction
Current Pharmaceutical Design Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research Novel Findings and Therapeutic Targets on Cardioprotection of Ischemia/ Reperfusion Injury in STEMI
Current Pharmaceutical Design Cardiac Dysfunction in Rats with Dietary-Induced Insulin Resistance Associated with Pharmacologically-induced Dyslipidemia
Current Pharmaceutical Design Interaction of the Heart and Lungs During Exercise: Physiology and Pathophysiology in Children with Congenital Heart Disease
Current Respiratory Medicine Reviews Association between Paraoxonase 1(PON1) Gene Polymorphisms and PON1 Enzyme Activity in Indian Patients with Coronary Artery Disease (CAD)
Current Pharmacogenomics and Personalized Medicine Drug Therapy in Brugada Syndrome
Current Drug Targets - Cardiovascular & Hematological Disorders Human Adipose-Derived Stem Cells with Great Therapeutic Potential
Current Stem Cell Research & Therapy Standardization of QRS Duration Measurement and LBBB Criteria in CRT Trials and Clinical Practice
Current Cardiology Reviews